Karmel W Choi1,2, Kelly M Shaffer1,3, Emily L Zale1,4, Christopher J Funes1, Karestan C Koenen1,2, Tara Tehan5, Jonathan Rosand6,7, Ana-Maria Vranceanu1,4,7. 1. Department of Psychiatry, Massachusetts General Hospital, Boston, MA. 2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA. 3. Department of Psychiatry & Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY. 4. Integrated Brain Health Clinical and Research Program, Massachusetts General Hospital, Boston, MA. 5. Patient Care Service, Massachusetts General Hospital, Boston, MA. 6. Division of Neurocritical and Emergency Neurology, Department of Neurology, Massachusetts General Hospital, Boston, MA. 7. McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA.
Abstract
OBJECTIVES: Informal caregivers-that is, close family and friends providing unpaid emotional or instrumental care-of patients admitted to ICUs are at risk for posttraumatic stress disorder. As a first step toward developing interventions to prevent posttraumatic stress disorder in ICU caregivers, we examined the predictive validity of psychosocial risk screening during admission for caregiver posttraumatic stress disorder at 3 and 6 months post hospitalization. DESIGN: An observational, prospective study. PARTICIPANTS: Ninety-nine caregivers were recruited as part of a longitudinal research program of patient-caregiver dyads in a neuroscience ICU. INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS: Caregiver posttraumatic stress disorder symptoms were assessed during admission (baseline), 3 months, and 6 months post hospitalization. We 1) characterized prevalence of clinically significant symptoms at each time point 2); calculated sensitivity and specificity of baseline posttraumatic stress disorder screening in predicting posttraumatic stress disorder at 3 and 6 months; and 3) used recursive partitioning to select potential baseline factors and examine the extent to which they helped predict clinically significant posttraumatic stress disorder symptoms at each time point. Rates of caregiver posttraumatic stress disorder remained relatively stable over time (16-22%). Screening for posttraumatic stress disorder at baseline predicted posttraumatic stress disorder at 3 and 6 months with moderate sensitivity (75-80%) and high specificity (92-95%). Screening for posttraumatic stress disorder at baseline was associated with caregiver anxiety, mindfulness (i.e., ability to be aware of one's thoughts and feelings in the moment), and bond with patient. Furthermore, baseline posttraumatic stress disorder screening was the single most relevant predictor of posttraumatic stress disorder at 3 and 6 months, such that other baseline factors did not significantly improve predictive ability. CONCLUSIONS: Screening neuroscience ICU caregivers for clinically significant posttraumatic stress disorder symptoms during admission is the single most important way to identify the majority of those likely to suffer from chronic posttraumatic stress disorder following discharge. Addressing early posttraumatic stress disorder symptoms and their psychosocial correlates during admission may help prevent chronic posttraumatic stress disorder in these at-risk caregivers.
OBJECTIVES: Informal caregivers-that is, close family and friends providing unpaid emotional or instrumental care-of patients admitted to ICUs are at risk for posttraumatic stress disorder. As a first step toward developing interventions to prevent posttraumatic stress disorder in ICU caregivers, we examined the predictive validity of psychosocial risk screening during admission for caregiver posttraumatic stress disorder at 3 and 6 months post hospitalization. DESIGN: An observational, prospective study. PARTICIPANTS: Ninety-nine caregivers were recruited as part of a longitudinal research program of patient-caregiver dyads in a neuroscience ICU. INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS:Caregiver posttraumatic stress disorder symptoms were assessed during admission (baseline), 3 months, and 6 months post hospitalization. We 1) characterized prevalence of clinically significant symptoms at each time point 2); calculated sensitivity and specificity of baseline posttraumatic stress disorder screening in predicting posttraumatic stress disorder at 3 and 6 months; and 3) used recursive partitioning to select potential baseline factors and examine the extent to which they helped predict clinically significant posttraumatic stress disorder symptoms at each time point. Rates of caregiver posttraumatic stress disorder remained relatively stable over time (16-22%). Screening for posttraumatic stress disorder at baseline predicted posttraumatic stress disorder at 3 and 6 months with moderate sensitivity (75-80%) and high specificity (92-95%). Screening for posttraumatic stress disorder at baseline was associated with caregiver anxiety, mindfulness (i.e., ability to be aware of one's thoughts and feelings in the moment), and bond with patient. Furthermore, baseline posttraumatic stress disorder screening was the single most relevant predictor of posttraumatic stress disorder at 3 and 6 months, such that other baseline factors did not significantly improve predictive ability. CONCLUSIONS: Screening neuroscience ICU caregivers for clinically significant posttraumatic stress disorder symptoms during admission is the single most important way to identify the majority of those likely to suffer from chronic posttraumatic stress disorder following discharge. Addressing early posttraumatic stress disorder symptoms and their psychosocial correlates during admission may help prevent chronic posttraumatic stress disorder in these at-risk caregivers.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Jennifer L McAdam; Kathleen A Dracup; Douglas B White; Dorothy K Fontaine; Kathleen A Puntillo Journal: Crit Care Med Date: 2010-04 Impact factor: 7.598
Authors: Sascha A van den Born-van Zanten; Dave A Dongelmans; Daniela Dettling-Ihnenfeldt; Roel Vink; Marike van der Schaaf Journal: Rehabil Psychol Date: 2016-05
Authors: Emma E Meyers; Kelly M Shaffer; Melissa Gates; Ann Lin; Jonathan Rosand; Ana-Maria Vranceanu Journal: Psychosomatics Date: 2019-12-04 Impact factor: 2.386
Authors: Ethan G Lester; Ryan A Mace; Sarah M Bannon; Paula J Popok; Melissa V Gates; Emma Meyers; Tara Tehan; Danielle Sagueiro; Jonathan Rosand; Eric A Macklin; Ana-Maria Vranceanu Journal: Neurocrit Care Date: 2021-04-21 Impact factor: 3.210
Authors: Sarah Bannon; Ethan G Lester; Melissa V Gates; Jessica McCurley; Ann Lin; Jonathan Rosand; Ana-Maria Vranceanu Journal: Pilot Feasibility Stud Date: 2020-05-25
Authors: Claudia Carmassi; Claudia Foghi; Valerio Dell'Oste; Carlo Antonio Bertelloni; Andrea Fiorillo; Liliana Dell'Osso Journal: Int J Environ Res Public Health Date: 2020-08-13 Impact factor: 3.390
Authors: Denham S Ward; Anthony R Absalom; Leanne M Aitken; Michele C Balas; David L Brown; Lisa Burry; Elizabeth Colantuoni; Douglas Coursin; John W Devlin; Franklin Dexter; Robert H Dworkin; Talmage D Egan; Doug Elliott; Ingrid Egerod; Pamela Flood; Gilles L Fraser; Timothy D Girard; David Gozal; Ramona O Hopkins; John Kress; Mervyn Maze; Dale M Needham; Pratik Pandharipande; Richard Riker; Daniel I Sessler; Steven L Shafer; Yahya Shehabi; Claudia Spies; Lena S Sun; Avery Tung; Richard D Urman Journal: Crit Care Med Date: 2021-10-01 Impact factor: 9.296
Authors: Qiang Zhang; Andrea K Knies; Jolanta Pach; Tara Kimbrough; Aida Martinez; Prerak Juthani; Stephanie Tu; Joan K Monin; Ana-Maria Vranceanu; David Y Hwang Journal: Crit Care Explor Date: 2022-08-29